Protagonist Therapeutics, Inc. (PTGX)
103.93
+3.98
(+3.98%)
USD |
NASDAQ |
May 13, 16:00
103.93
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Cash from Investing (Quarterly) : 90.89M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -1.04B |
| AbbVie, Inc. | -574.00M |
| Insmed, Inc. | 265.52M |
| Madrigal Pharmaceuticals, Inc. | 192.19M |
| PTC Therapeutics, Inc. | -93.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.94M |
| Cash from Financing (Quarterly) | 23.37M |
| Free Cash Flow | -117.90M |
| Free Cash Flow Per Share (Quarterly) | -0.6974 |
| Free Cash Flow to Equity (Quarterly) | -48.61M |
| Free Cash Flow to Firm (Quarterly) | -49.16M |
| Free Cash Flow Yield | -1.73% |